The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Poziotinib shows activity and durability of responses in subgroups of previously treated EGFR exon 20 NSCLC patients.
 
Xiuning Le
Consulting or Advisory Role - AstraZeneca; EMD Serono; Lilly
Research Funding - Lilly
 
Jonathan Wade Goldman
Consulting or Advisory Role - Amgen; AstraZeneca; Bristol-Myers Squibb; Celgene; Clovis Oncology; Genentech/Roche; Lilly; Trovagene; Vortex Biosciences
Speakers' Bureau - Merck
Research Funding - Abbvie; Array BioPharma; Astellas Pharma; Astex Pharmaceuticals; AstraZeneca/MedImmune; Bristol-Myers Squibb; Celgene; Clovis Oncology; Corvus Pharmaceuticals; Genentech/Roche; Lilly; Spectrum Pharmaceuticals; Threshold Pharmaceuticals
 
Jeffrey Melson Clarke
Consulting or Advisory Role - AstraZeneca; Guardant Health; Merck; NGM Biopharmaceuticals; Pfizer; Pfizer
Speakers' Bureau - Guardant Health; Merck
Research Funding - Abbvie; Adaptimmune; Array BioPharma; AstraZeneca; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; medpacto; Moderna Therapeutics; Spectrum Pharmaceuticals
Travel, Accommodations, Expenses - AstraZeneca; Merck; NGM Biopharmaceuticals; Pfizer
(OPTIONAL) Uncompensated Relationships - Lung Cancer Initiative of North Carolina
 
Nishan Tchekmedyian
Employment - Pacific Shores Medical Group
Leadership - Pacific Shores Medical Group
Stock and Other Ownership Interests - Biomarin (I); Exelixis (I); global therapeutics (I); Halozyme (I); Infinity Pharmaceuticals (I); Portola Pharmaceuticals; Trillium Therapeutics (I)
Consulting or Advisory Role - Foundation Medicine; IntrinsiQ; Seagen
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Cullinan Oncology (Inst); Rain Therapeutics (Inst); Spectrum Pharmaceuticals (Inst); Takeda (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - IntrinsiQ
 
Zofia Piotrowska
Consulting or Advisory Role - AstraZeneca; Genentech; Guardant Health; Immunogen; Incyte; Lilly; Medtronic; Spectrum Pharmaceuticals
Research Funding - ARIAD/Takeda (Inst); AstraZeneca (Inst); Guardant Health (Inst); Johnson & Johnson (Inst); Novartis (Inst); Spectrum Pharmaceuticals (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - ARIAD/Takeda; AstraZeneca; Genentech
 
David Chu
Research Funding - Spectrum Pharmaceuticals
 
Gajanan Bhat
Employment - Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
 
Francois M. Lebel
Employment - Spectrum Pharmaceuticals
Leadership - Spectrum Pharmaceuticals
Stock and Other Ownership Interests - Spectrum Pharmaceuticals
 
Mark A. Socinski
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Genentech; Guardant Health; Lilly; Merck; Roche/Genentech
Consulting or Advisory Role - AstraZeneca/MedImmune; Genentech; Lilly
Speakers' Bureau - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Genentech
Research Funding - AstraZeneca/MedImmune (Inst); Genentech (Inst); Spectrum Pharmaceuticals (Inst)